Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Biochemical Pharmacology|May 15, 2002
Expression of p53-family members and associated target molecules in breast cancer cell lines in response to vincristine treatmentMuriel Vayssade, Laetitia Faridoni-Laurens, Jean Bénard, et al.Plos One|November 22, 2013
WNT5A encodes two isoforms with distinct functions in cancersMatthieu Bauer, Jean Bénard, Terry Gaasterland, et al.Cancer Letters|June 1, 2005
Wnt-5a gene expression in malignant human neuroblastsEtienne Blanc, David Goldschneider, Sétha Douc-Rasy, et al.BMC Cancer|April 1, 2009
Fenretinide-induced caspase-8 activation and apoptosis in an established model of metastatic neuroblastomaGilda Raguénez, Annick Mühlethaler-Mottet, Roland Meier, et al.Cancer Letters|July 26, 2003
When p53 needs p73 to be functional - forced p73 expression induces nuclear accumulation of endogenous p53 proteinDavid Goldschneider, Etienne Blanc, Gilda Raguenez, et al.BMC Cancer|September 4, 2010
p21Waf1 expression is regulated by nuclear intermediate filament vimentin in neuroblastomaXénia Mergui, Marie-Line Puiffe, Dominique Valteau-Couanet, et al.International Journal of Cancer|April 26, 2005
P73 functionally replaces p53 in Adriamycin-treated, p53-deficient breast cancer cellsMuriel Vayssade, Hedi Haddada, Laetitia Faridoni-Laurens, et al.Journal of Cell Science|March 3, 2005
The neurogene BTG2TIS21/PC3 is transactivated by DeltaNp73alpha via p53 specifically in neuroblastoma cellsDavid Goldschneider, Karine Million, Anne Meiller, et al.International Journal of Oncology|June 15, 2006
Differential regulation of p73 variants in response to cisplatin treatment in SH-SY5Y neuroblastoma cellsKarine Million, Emilie Horvilleur, David Goldschneider, et al.Molecular Oncology|October 21, 2015
WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastomaCaroline Masserot, Qingyuan Liu, Eric Nguyen, et al.Pageof 6